Patent · US Active

Implantable drug delivery device with bladder retention feature

US9457176B2 · kind B2 · utility

17Cited by
9References
33Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 6, 2011
Grant dateOct 4, 2016
Priority date
Expiry dateOct 6, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61M2210/1085
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Implantable devices and methods for controlled drug delivery are provided. The device includes a device structure deformable between a retention shape and a low profile shape for deployment in the bladder of a patient and has a drug reservoir lumen in which a drug formulation is housed. The device also includes a buoyancy retention portion, which includes a volume of entrapped air or a gas-generating or effervescent powder which will generate a volume of entrapped air following contact with urine in the bladder. The buoyancy retention portion may include a water permeable and/or biodegradable wall, which can release the entrapped air following drug release, to cause the device to sink into the bladder neck to facilitate device expulsion without the need for a device retrieval medical procedure.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.